In clinical trial [ 15 ], use of ICS/LABA combination over three years showed a decrease in mortality that almost reached statistical significance (HR=0.825, p = 0.052).
← all excerpts
Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap.
1
0.0520
0.0520